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Bardet-Biedl (BBS, OMIM 209900) and Alström (AS,
OMIM #203800) syndromes belong to a group of hetero-
genic disorders called ciliopathies where alterations on
the cilia and the ciliary mechanisms are implicated.
The genetically heterogeneous nature of BBS, with fifteen
genes identified (BBS1-BBS15) to date, is also shown in
the considerable inter- and intra-familial variation in the
phenotype. Mutation screening of the involved genes has
resulted in the identification of approximately 70% of the
causative mutations, indicating that additional BBS genes
have to be identified. ALMS1 is the only gene associated
with the development of AS. ALMS1 encodes a novel pro-
tein, widely expressed and with unknown molecular func-
tion. We recruited 81 BBS families with 105 affected
patients (44 females/ 61 males) and 5 AS families with 5
patients (4 females/ 1 male). Molecular analysis was per-
formed using three strategies: homozygosity mapping
when the family was consanguineous, BBS genotyping
chip (Asper Ohthalmics), and direct sequencing. We were
able to detected at least one mutation in 47% of the BBS
patients. The allelic implication for the major genes in our
patients was as follows: BBS1 (56%), BBS10 (20%), BBS12
(11%), BBS6 (7%), BBS3 (4%), BBS2 (1%) and BBS5 (1%).
In AS patients we could detect the two responsible muta-
tions in two families, and only one mutation in heterozy-
gous state in a third family. The molecular study of these
syndromes can be very helpful in providing a diagnosis in
this patients, hence appropriate genetic counselling for
families and adequate medical follow-up for affected
children.
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